Eschar: an important clue to diagnosis

von Sundriyal, Deepak, Kumar, Naveen, Chandrasekharan, Arun, Sharma, Brijesh
Veröffentlicht 2013

Mauskopf facies

von Sundriyal, Deepak, Kumar, Naveen, Chandrasekharan, Arun, Gadpayle, Adesh Kumar
Veröffentlicht 2013

Activation of phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway and response to everolimus in endocrine receptor-positive metastatic breast cancer – A retrospec...

von Bajpai, Jyoti, Ramaswamy, Anant, Chandrasekharan, Arun, Mishra, Surya, Shet, Tanuja, Gupta, Sudeep, Badwe, R. A.
Veröffentlicht in South Asian J Cancer (2017)

Long-term survival outcomes of technically unresectable carcinoma maxilla postinduction chemotherapy

von Dhumal, Sachin Babanrao, Patil, Vijay M., Joshi, Amit, Noronha, Vanita, Chandrasekharan, Arun, Pai, Prathamesh, Prabhash, Kumar
Veröffentlicht in South Asian J Cancer (2018)

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid

von Dhumal, Sachin, Chandrasekharan, Arun, Patil, Vijay, Noronha, Vanita, Joshi, Amit, Puranik, Ameya, Rangarajan, Venkatesh, Prabhash, Kumar
Veröffentlicht in South Asian J Cancer (2019)

Metronomic palliative chemotherapy in maxillary sinus tumor

von Patil, Vijay M., Noronh, Vanita, Joshi, Amit, Karpe, Ashay, Talreja, Vikas, Chandrasekharan, Arun, Dhumal, Sachin, Prabhash, Kumar
Veröffentlicht in South Asian J Cancer (2016)

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer

von Noronha, Vanita, Sahu, Arvind, Patil, Vijay M., Joshi, Amit, Ramaswamy, Anant, Chandrasekharan, Arun, Kadam, Nandkumar, Prabhash, Kumar
Veröffentlicht in South Asian J Cancer (2016)

A cross-sectional audit of distress in patients undergoing adjuvant therapy or follow-up in central nervous system malignancies

von Patil, Vijay M, Malhotra, Mridul, Tonse, Raees, Deodhar, Jayita, Chandrasekharan, Arun, Pande, Nikhil, Bhattacharjee, Atanu, Jalali, Rakesh
Veröffentlicht in Neurooncol Pract (2019)

Palliative chemotherapy in carcinoma nasopharynx

von Patil, Vijay M., Joshi, Amit, Noronha, Vanita, Talreja, Vikas, Simha, Vijai, Dhumal, Sachin, Bandekar, Bhavesh, Chandrasekharan, Arun, Prabhash, Kumar
Veröffentlicht in South Asian J Cancer (2019)

Antiemetic prophylaxis with temozolomide: an audit from a tertiary care center

von Patil, Vijay M, Chandrasekharan, Arun, Vallathol, Dilip Harindran, Malhotra, Mridul, Abhinav, Ram, Agarwal, Priti, Rajpurohit, Anu, Tonse, Raees, Bhattacharjee, Atanu, Jalali, Rakesh
Veröffentlicht in Neurooncol Pract (2019)

Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non–High-Dose Methotrexate–Based, Dose-Dense Combination Chemotherapy, in a...

von Bajpai, Jyoti, Chandrasekharan, Arun, Simha, Vijai, Talreja, Vikas, Karpe, Ashay, Pandey, Nikihil, Singh, Ashish, Rekhi, Bharat, Vora, Tushar, Ghosh, Jaya, Banavali, Shripad, Gupta, Sudeep
Veröffentlicht in J Glob Oncol (2018)

Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy

von Patil, Vijay M, Pande, Nikhil, Chandrasekharan, Arun, M, Chandrakanth, Tonse, Raees, Krishnatry, Rahul, Goda, Jayant S, Dsouza, Hollis, Vallathol, Dilip Harindran, Chakraborty, Santam, Gupta, Tejpal, Jalali, Rakesh
Veröffentlicht in CNS Oncol (2018)

Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients

von Patil, Vijay, Joshi, Amit, Noronha, Vanita, Bhattacharjee, Atanu, Dhumal, Sachin, Chandrakanth, M. V., Karpe, Ashay, Talreja, Vikas, Chandrasekharan, Arun, Turkar, Siddharth, Pande, Nikhil, Ramaswamy, Anant, Prabhash, Kumar
Veröffentlicht in South Asian J Cancer (2018)

Distress Management in Patients With Head and Neck Cancer Before Start of Palliative Chemotherapy: A Practical Approach

von Patil, Vijay, Noronha, Vanita, Joshi, Amit, Deodhar, Jayita, Goswami, Savita, Chakraborty, Santam, Ramaswamy, Anant, Dhumal, Sachin, M.V., Chandrakanth, Karpe, Ashay, Pande, Nikhil, Talreja, Vikas, Chandrasekharan, Arun, Turkar, Siddharth, Prabhash, Kumar
Veröffentlicht in J Glob Oncol (2018)

Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell l...

von Patil, Vijay, Joshi, Amit, Noronha, Vanita, Agarwala, Vivek, Chougule, Anuradha, Kanan, Sadhana, Bhattacharjee, Atanu, Chandrasekharan, Arun, Pande, Nikhil, Simha, Vijai, Goud, Supriya, More, Sucheta, Kumar, Rajiv, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Veröffentlicht in Oncotarget (2019)

Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy

von Noronha, Vanita, Patil, Vijay, Joshi, Amit, Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, More, Sucheta, Goud, Supriya, Karpe, Ashay, Ramaswamy, Anant, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Veröffentlicht in Ecancermedicalscience (2017)

Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?

von Joshi, Amit, Patil, Vijay, Noronha, Vanita, Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Veröffentlicht in Lung India (2018)

Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?

von Joshi, Amit, Noronha, Vanita, Patil, Vijay M., Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Veröffentlicht in Chemother Res Pract (2017)

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

von Patil, Vijay Maruti, Noronha, Vanita, Joshi, Amit, Choughule, Anuradha Bharat, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Veröffentlicht in ESMO Open (2017)

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer

von Noronha, Vanita, Patil, Vijay Maruti, Joshi, Amit, Mahimkar, Manoj, Patel, Usha, Pandey, Manish Kumar, Chandrasekharan, Arun, Dsouza, Hollis, Bhattacharjee, Atanu, Mahajan, Abhishek, Sabale, Nilesh, Agarwal, Jai Prakash, Ghosh-Laskar, Sarbani, Budrukkar, Ashwini, D’Cruz, Anil K., Chaturvedi, Pankaj, Pai, Prathamesh S., Chaukar, Devendra, Nair, Sudhir, Thiagarajan, Shivakumar, Banavali, Shripad, Prabhash, Kumar
Veröffentlicht in Oncotarget (2020)